首页> 外文期刊>Stem cells international >Identification of New Rat Bone Marrow-Derived Population of Very Small Stem Cell with Oct-4A and Nanog Expression by Flow Cytometric Platforms
【24h】

Identification of New Rat Bone Marrow-Derived Population of Very Small Stem Cell with Oct-4A and Nanog Expression by Flow Cytometric Platforms

机译:流式细胞仪鉴定Oct-4A和nanog表达的新的大鼠骨髓衍生的非常小的干细胞群体

获取原文
           

摘要

Very small embryonic-like stem cells (VSELs) represent a unique rare population of adult stem cells (SCs) sharing several structural, genetic, biochemical, and functional properties with embryonic SCs and have been identified in several adult murine and human tissues. However, rat bone marrow- (BM-) derived SCs closely resembling murine or human VSELs have not been described. Thus, we employed multi-instrumental flow cytometric approach including classical and imaging cytometry and we established that newly identified population of nonhematopoietic cells expressing CD106 (VCAM-I) antigen contains SCs with very small size, expressing markers of pluripotency (Oct-4A and Nanog) on both mRNA and protein levels that indicate VSEL population. Based on our experience in both murine and human VSEL isolation procedures by fluorescence-activated cell sorting (FACS), we also optimized sorting protocol for separation of CD45−/Lin−/CD106+rat BM-derived VSELs from wild type and eGFP-expressing rats, which are often used as donor animals for cell transplantations in regenerative studiesin vivo. Thus, this is a first study identifying multiantigenic phenotype and providing sorting protocols for isolation VSELs from rat BM tissue for further examining of their functional propertiesin vitroas well as regenerative capacity in distinctin vivorat models of tissue injury.
机译:很小的类胚胎干细胞(VSEL)代表成年干细胞(SC)的独特稀有种群,与成年干细胞具有几种结构,遗传,生化和功能特性,并且已在几种成年鼠和人组织中得到鉴定。但是,尚未描述与鼠或人VSEL非常相似的大鼠骨髓(BM-)衍生的SC。因此,我们采用了多仪器流式细胞术,包括经典的流式细胞术和成像流式细胞术,并且我们建立了新鉴定的表达CD106(VCAM-1)抗原的非造血细胞群体,其SC的大小非常小,能表达多能性标志物(Oct-4A和Nanog )表示VSEL种群的mRNA和蛋白质水平。基于我们通过荧光激活细胞分选(FACS)在鼠类和人VSEL分离过程中的经验,我们还优化了用于从野生型和eGFP表达中分离CD45- / Lin- / CD106 + rat BM来源的VSEL的分选方案大鼠,在体内再生研究中通常用作供体动物进行细胞移植。因此,这是鉴定多抗原表型并为从大鼠BM组织中分离VSEL提供分选方案的第一项研究,以进一步检查其在体外的功能特性以及在不同的组织损伤体内模型中的再生能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号